BIOGEN INC. Annual Operating Income (Loss) in USD from 2010 to 2021

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Biogen Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
Biogen Inc. Operating Income (Loss) for the quarter ending March 31, 2022 was $611M, a 37.3% decline year-over-year.
Biogen Inc. Operating Income (Loss) for the twelve months ending March 31, 2022 was $2.48B, a 33.1% decline year-over-year.
Biogen Inc. annual Operating Income (Loss) for 2021 was $2.84B, a 37.6% decline from 2020.
Biogen Inc. annual Operating Income (Loss) for 2020 was $4.55B, a 35.4% decline from 2019.
Biogen Inc. annual Operating Income (Loss) for 2019 was $7.04B, a 19.6% increase from 2018.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2021	$2.84B	-$1.71B	-37.6%	Jan 1, 2021	Dec 31, 2021	10-K	2022-02-03
2020	$4.55B	-$2.49B	-35.4%	Jan 1, 2020	Dec 31, 2020	10-K	2022-02-03
2019	$7.04B	+$1.15B	+19.6%	Jan 1, 2019	Dec 31, 2019	10-K	2022-02-03
2018	$5.89B	+$543M	+10.2%	Jan 1, 2018	Dec 31, 2018	10-K	2021-02-03
2017	$5.35B	+$194M	+3.77%	Jan 1, 2017	Dec 31, 2017	10-K	2020-02-06
2016	$5.15B	+$261M	+5.33%	Jan 1, 2016	Dec 31, 2016	10-K	2019-02-06
2015	$4.89B	+$919M	+23.1%	Jan 1, 2015	Dec 31, 2015	10-K	2018-02-01
2014	$3.97B	+$1.46B	+57.9%	Jan 1, 2014	Dec 31, 2014	10-K	2017-02-02
2013	$2.52B	+$660M	+35.5%	Jan 1, 2013	Dec 31, 2013	10-K	2016-02-03
2012	$1.86B	+$131M	+7.61%	Jan 1, 2012	Dec 31, 2012	10-K	2015-02-04
2011	$1.72B	+$476M	+38.1%	Jan 1, 2011	Dec 31, 2011	10-K	2014-02-06
2010	$1.25B			Jan 1, 2010	Dec 31, 2010	10-K	2013-02-05

Showing 1 to 12 of 12 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.